Insiders · PHAS

PHAS insider transactions

PhaseBio Pharmaceuticals Inc. (PHAS) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for PHAS

• 1118d
  SEC Form 4 filed by Van Den Broek Richard

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1118d
  SEC Form 4 filed by Thorp Clay

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1118d
  SEC Form 4 filed by Humphries William D.

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1118d
  SEC Form 4 filed by Harrigan Edmund

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1118d
  SEC Form 4 filed by Sapir Alex

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1118d
  SEC Form 4 filed by Loewy Caroline M

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1118d
  SEC Form 4 filed by Hutson Nancy J

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1323d
  SEC Form 4: New Enterprise Associates 13 Lp sold $262,264 worth of shares (1,784,109 units at $0.15)

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1461d
  SEC Form 4 filed by Humphries William D. (Amendment)

  4/A - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1478d
  SEC Form 4: Arnold Susan Elizabeth was granted 10,917 shares, increasing direct ownership by 36% to 41,236 units

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1478d
  SEC Form 4: Mow Jonathan P was granted 10,918 shares, increasing direct ownership by 9% to 132,502 units

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1478d
  SEC Form 4: Burkhardt Glen was granted 11,248 shares and sold $8,886 worth of shares (11,248 units at $0.79) as part of a pre-agreed trading plan

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1478d
  SEC Form 4: Hanson Kristopher was granted 4,831 shares, increasing direct ownership by 133% to 8,463 units

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1478d
  SEC Form 4: Birchall Jonathan was granted 20,000 shares

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1478d
  SEC Form 4: Sharp John P was granted 6,026 shares, increasing direct ownership by 10% to 65,767 units

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1482d
  SEC Form 4: Hutson Nancy J bought $9,240 worth of shares (3,000 units at $3.08) (Amendment)

  4/A - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1482d
  SEC Form 4 filed by Humphries William D.

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1482d
  SEC Form 4 filed by Thorp Clay

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1482d
  SEC Form 4 filed by Hutson Nancy J

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1482d
  SEC Form 4 filed by Sapir Alex

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1482d
  SEC Form 4 filed by Loewy Caroline M

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1482d
  SEC Form 4 filed by Harrigan Edmund

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1482d
  SEC Form 4 filed by Van Den Broek Richard

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1563d
  SEC Form 4 filed by Burkhardt Glen

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1563d
  SEC Form 4 filed by Sharp John P

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1563d
  SEC Form 4 filed by Birchall Jonathan

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1563d
  SEC Form 4 filed by Lee John Sang

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1563d
  SEC Form 4 filed by Arnold Susan Elizabeth

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1563d
  SEC Form 4 filed by Hanson Kristopher

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1563d
  SEC Form 4 filed by Mow Jonathan P

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1660d
  SEC Form 4: Mow Jonathan P was granted 5,623 shares, increasing direct ownership by 3% to 172,473 units

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1660d
  SEC Form 4: Arnold Susan Elizabeth was granted 2,559 shares, increasing direct ownership by 9% to 30,319 units

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1660d
  SEC Form 4: Sharp John P was granted 2,017 shares, increasing direct ownership by 3% to 59,741 units

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1660d
  SEC Form 4: Hanson Kristopher was granted 1,545 shares, increasing direct ownership by 74% to 3,632 units

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1660d
  SEC Form 4: Burkhardt Glen sold $13,665 worth of shares (5,766 units at $2.37) as part of a pre-agreed trading plan and was granted 5,766 shares

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1674d
  SEC Form 4 filed by Birchall Jonathan

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1674d
  SEC Form 3 filed by new insider Birchall Jonathan

  3 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1675d
  SEC Form 4: Hutson Nancy J exercised 33,760 shares at a strike of $2.49

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1680d
  SEC Form 4: Mow Jonathan P exercised 20,000 shares at a strike of $1.24, increasing direct ownership by 14% to 166,850 units

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1680d
  SEC Form 4: Sharp John P exercised 7,500 shares at a strike of $1.68, increasing direct ownership by 15% to 57,724 units

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1730d
  SEC Form 4 filed by Humphries William D.

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1730d
  SEC Form 3 filed by new insider Humphries William D.

  3 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1741d
  SEC Form 4: Arnold Susan Elizabeth exercised 4,519 units of Common Stock at a strike of $1.74, increasing direct ownership by 19% to 27,760 units (Amendment)

  4/A - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1741d
  SEC Form 4: Sharp John P exercised 7,500 units of Common Stock at a strike of $1.68, increasing direct ownership by 18% to 50,224 units (Amendment)

  4/A - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1745d
  SEC Form 4: Mow Jonathan P exercised 20,000 units of Common Stock at a strike of $1.24, increasing direct ownership by 16% to 146,850 units

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1756d
  SEC Form 4: Hutson Nancy J bought $9,240 worth of Common Stock (3,000 units at $3.08)

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1757d
  SEC Form 4: Thorp Clay bought $30,000 worth of Common Stock (10,000 units at $3.00), increasing direct ownership by 44% to 32,943 units

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1771d
  SEC Form 4: Sharp John P was granted 7,500 units of Common Stock, increasing direct ownership by 18% to 50,224 units

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1792d
  SEC Form 4: Arnold Susan Elizabeth was granted 4,519 units of Common Stock, increasing direct ownership by 19% to 27,760 units

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1832d
  SEC Form 4 filed by PhaseBio Pharmaceuticals, Inc.

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1832d
  SEC Form 4 filed by Sapir Alex

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1832d
  SEC Form 4 filed by PhaseBio Pharmaceuticals, Inc.

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1832d
  SEC Form 4 filed by Klein Peter Justin

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1832d
  SEC Form 4 filed by PhaseBio Pharmaceuticals, Inc.

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1832d
  SEC Form 4 filed by Hutson Nancy J

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1832d
  SEC Form 4 filed by Thorp Clay

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1843d
  SEC Form 4: Burkhardt Glen was granted 3,811 units of Common Stock and sold $12,538 worth of Common Stock (3,811 units at $3.29)

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1843d
  SEC Form 4: Hanson Kristopher was granted 1,088 units of Common Stock, increasing direct ownership by 109% to 2,087 units

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1947d
  SEC Form 4 filed by P Jonathan Mow

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)
• 1947d
  SEC Form 4 filed by Kristopher Hanson

  4 - PhaseBio Pharmaceuticals Inc (0001169245) (Issuer)